A detailed history of Kg&L Capital Management,Llc transactions in Amgen Inc stock. As of the latest transaction made, Kg&L Capital Management,Llc holds 2,818 shares of AMGN stock, worth $789,237. This represents 0.3% of its overall portfolio holdings.

Number of Shares
2,818
Previous 2,854 1.26%
Holding current value
$789,237
Previous $891,000 1.8%
% of portfolio
0.3%
Previous 0.31%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$309.38 - $337.38 $11,137 - $12,145
-36 Reduced 1.26%
2,818 $907,000
Q2 2024

Jul 22, 2024

SELL
$262.75 - $319.31 $283,770 - $344,854
-1,080 Reduced 27.45%
2,854 $891,000
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $486,923 - $587,778
1,811 Added 85.3%
3,934 $1.12 Million
Q4 2023

Jan 23, 2024

SELL
$255.7 - $288.46 $33,241 - $37,499
-130 Reduced 5.77%
2,123 $611,000
Q3 2023

Oct 19, 2023

SELL
$218.65 - $271.46 $648,297 - $804,878
-2,965 Reduced 56.82%
2,253 $605,000
Q2 2023

Jul 20, 2023

SELL
$214.27 - $253.37 $128,133 - $151,515
-598 Reduced 10.28%
5,218 $1.16 Million
Q1 2023

Apr 19, 2023

BUY
$225.79 - $275.2 $586,376 - $714,694
2,597 Added 80.68%
5,816 $1.41 Million
Q4 2022

Jan 18, 2023

SELL
$229.03 - $291.01 $32,980 - $41,905
-144 Reduced 4.28%
3,219 $0
Q3 2022

Oct 24, 2022

SELL
$224.46 - $253.15 $10,100 - $11,391
-45 Reduced 1.32%
3,363 $758,000
Q2 2022

Jul 22, 2022

SELL
$230.71 - $256.74 $145,116 - $161,489
-629 Reduced 15.58%
3,408 $829,000
Q1 2022

Apr 22, 2022

SELL
$219.27 - $242.57 $449,284 - $497,025
-2,049 Reduced 33.67%
4,037 $976,000
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $295,933 - $338,668
1,488 Added 32.36%
6,086 $1.37 Million
Q3 2021

Oct 14, 2021

BUY
$212.27 - $248.7 $282,319 - $330,771
1,330 Added 40.7%
4,598 $978,000
Q2 2021

Jul 15, 2021

BUY
$233.58 - $259.14 $763,339 - $846,869
3,268 New
3,268 $797,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kg&L Capital Management,Llc Portfolio

Follow Kg&L Capital Management,Llc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kg&L Capital Management,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Kg&L Capital Management,Llc with notifications on news.